Helen Torley
CIK 1528185 · PRESIDENT AND CEO · last filed 2026-10-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
HTI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN DIEGO, CA 92130
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HALO | PRESIDENT AND CEO | 782,970 | $102.98 | $80.63M | -$19.48M | 4 | 2026-10-08 |
| HTI | PRESIDENT AND CEO | 767,780 | — | — | -$83.25M | 89 | 2026-06-03 |
| DGX | Director | 6,260 | $258.44 | $1.62M | $0 | 7 | 2021-05-25 |
| Relypsa Inc (RLYP) Delisted | Director | 0 | — | — | -$19.6K | 5 | 2016-09-02 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | EVP, Chief Commercial Officer | 35,911 | — | — | -$4.40M | 14 | 2013-09-05 |
Recent Filings · Page 2 of 15
145 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-04 | HTI | Mixed | — | -$2.87M | EDGAR |
| 2026-02-24 | HTI | Mixed | +18,049 | -$1.50M | EDGAR |
| 2026-02-17 | HTI | Mixed | +41,012 | -$3.82M | EDGAR |
| 2026-02-11 | HTI | Grant (A) | — | $0 | EDGAR |
| 2026-02-05 | HTI | Mixed | — | -$3.25M | EDGAR |
| 2026-02-03 | HALO | Notice (144) | −150,000 | -$11.17M | EDGAR |
| 2025-12-11 | HTI | Grant (A) | — | $0 | EDGAR |
| 2025-12-01 | HTI | Mixed | −25,000 | -$1.01M | EDGAR |
| 2025-11-12 | HTI | Mixed | — | -$3.68M | EDGAR |
| 2025-10-03 | HTI | Mixed | — | -$3.83M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.